11,950
Total Claims
$1.4M
Drug Cost
1,451
Beneficiaries
$961
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-18%
Cost per patient vs peers
$961 vs $1,174 avg
+56%
Brand preference vs peers
13.8% vs 8.9% avg
Brand vs Generic
86% generic
Brand: 1,652 claims · $1.2M
Generic: 10,298 claims · $210K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 410 | $342K |
| Rivaroxaban | 328 | $280K |
| Evolocumab | 274 | $202K |
| Sacubitril/Valsartan | 143 | $136K |
| Alirocumab | 108 | $65K |
| Empagliflozin | 62 | $53K |
| Rosuvastatin Calcium | 1,613 | $31K |
| Icosapent Ethyl | 48 | $24K |
| Bempedoic Acid/Ezetimibe | 29 | $17K |
| Ranolazine | 109 | $16K |
| Pitavastatin Calcium | 37 | $16K |
| Bempedoic Acid | 14 | $14K |
| Ezetimibe | 546 | $14K |
| Metoprolol Succinate | 775 | $13K |
| Atorvastatin Calcium | 788 | $11K |
Prescribing Profile
74
Unique Drugs
$810K
Patient Profile
73
Avg Age
54%
Female
1.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About